59 related articles for article (PubMed ID: 9202313)
41. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
Honegger P; Matthieu JM; Lassmann H
Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
[TBL] [Abstract][Full Text] [Related]
42. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
43. Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice.
Menon K; Wu Y; Haas J; Sahu SK; Yang B; Zaheer A
Neurosci Res; 2007 Jun; 58(2):156-63. PubMed ID: 17383764
[TBL] [Abstract][Full Text] [Related]
44. First attack in multiple sclerosis: harbinger or history?
Scolding N
Lancet Neurol; 2003 Sep; 2(9):526. PubMed ID: 12941570
[No Abstract] [Full Text] [Related]
45. Central nervous system myelin: structure, function, and pathology.
Deber CM; Reynolds SJ
Clin Biochem; 1991 Apr; 24(2):113-34. PubMed ID: 1710177
[TBL] [Abstract][Full Text] [Related]
46. Genetic dissection of myelin galactolipid function.
Dupree JL; Popko B
J Neurocytol; 1999; 28(4-5):271-9. PubMed ID: 10739570
[TBL] [Abstract][Full Text] [Related]
47. Biological methylation of myelin basic protein: enzymology and biological significance.
Kim S; Lim IK; Park GH; Paik WK
Int J Biochem Cell Biol; 1997 May; 29(5):743-51. PubMed ID: 9251242
[TBL] [Abstract][Full Text] [Related]
48. Neural cell markers and their applications to neurology.
Kennedy PG
J Neuroimmunol; 1982 Jan; 2(1):35-53. PubMed ID: 6185534
[TBL] [Abstract][Full Text] [Related]
49. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
Menon KK; Piddlesden SJ; Bernard CC
J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
[TBL] [Abstract][Full Text] [Related]
50. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
Dyer CA
Mol Neurobiol; 1993; 7(1):1-22. PubMed ID: 8391270
[TBL] [Abstract][Full Text] [Related]
51. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
52. The structure and function of myelin oligodendrocyte glycoprotein.
Johns TG; Bernard CC
J Neurochem; 1999 Jan; 72(1):1-9. PubMed ID: 9886048
[TBL] [Abstract][Full Text] [Related]
53. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
Jaśkiewicz E
Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies in inflammatory demyelinating diseases of the central nervous system.
Lalive PH
Swiss Med Wkly; 2008 Nov; 138(47-48):692-707. PubMed ID: 18951202
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
